Interpace Biosciences, Inc. (IDXG) News
Follow Interpace Biosciences, Inc. (IDXG) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Interpace Biosciences Sees Preliminary Q3 Revenue of $10.1M–$10.4M
The company expects unaudited Q3 2026 revenue of $10.1 million–$10.4 million, up about 11%–14% from Q2 2026 and 15%–18% from Q3 2025, subject to closing and review.
EQUITY | Oct 15, 2026, 12:32 AM UTC
L
Interpace Biosciences reverse stock split effective Aug 27
Interpace Biosciences’ reverse stock split will become effective at 12:01 AM ET on Aug 27.
EQUITY | Aug 26, 2026, 08:27 PM UTC